Bioprocess Instruments Market Size, Share, Growth, and Industry Analysis by Type (Cell Expansion, Flow Cytometry, Biologics Safety Testing, Cell Line Development, Tangential Flow Filtration, Cell Counters, Virus Filtration, Cell Culture, Pyrogen Testing & Single-Use Bioprocessing), By Application (Pharmaceutical Industry, Biopharmaceutical Industry, R&D Labs & Medical Laboratories) & Regional Forecast By 2031

Updated On: 22 April 2024

Bioprocess Instruments Market Report Overview

• 

• Request a Free Sample to learn more about this report

The global bioprocess instruments market size was USD 1290 million in 2022, as per our research, the market is expected to reach USD 3041.73 million in 2031, exhibiting a CAGR of 10.0% during the forecast period. 

The global COVID-19 pandemic has been unprecedented and staggering, with bioprocess instruments industry experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

The bioprocess instruments industry refers to the market for specialized tools and equipment used in the biotechnology and biopharmaceutical industries for monitoring and controlling various stages of bioprocessing. This includes instruments used in research and development, process development, and production-scale manufacturing of biologics such as vaccines, antibodies, enzymes, and drugs. They are specialized tools used in the biotechnology and biopharmaceutical industries to monitor and control various stages of bioprocessing.

Bioprocessing involves the use of living cells or organisms to produce biological products such as vaccines, antibodies, enzymes, and drugs. They are critical for ensuring the consistency and quality of these products by providing real-time monitoring and control of key parameters such as temperature, pH, dissolved oxygen, and biomass concentration. Bioreactors are vessels designed to support the growth and metabolism of microorganisms or animal cells used in bioprocessing. Fermentation monitors instruments are used to monitor the growth of microorganisms and the production of metabolites in fermentation processes.

COVID-19 Impact: Industry Shutdown Causes Market Distortion

The COVID-19 outbreak caused problems for manufacturers of healthcare materials, including unstable markets, a drop in customer confidence, and difficulties with import and export commerce. The sourcing of raw materials, packaging, and distribution are all parts of the global supply chain. Due to lockdowns, moving commodities, labels, and other items has become difficult. In addition to having an immediate influence on markets, supply chains, supply and demand, and all of these other things, it also had a financial impact on the markets for healthcare. The pandemic altered the dynamics of the industry, compelling organizations to redesign every aspect of their operational frameworks in order to preserve stability amidst the disturbances. Aside from that, the companies' business operations have been affected by the outbreak, which has an effect on the overall healthcare industry. This has partially impacted the bioprocess instruments industry.

LATEST TRENDS

"Biologics to Boost the Market Growth"

The growing demand for biologics is a major trend driving the growth of the bioprocess instruments industry. Biologics are complex molecules that are produced using living cells or organisms, and they are used to treat a wide range of diseases such as cancer, autoimmune disorders, and infectious diseases. As the population ages and the prevalence of these diseases increases, the demand for biologics is expected to continue to grow. They are critical tools in the production of biologics. They are used to monitor and control the various stages of bioprocessing, including cell culture, fermentation, purification, and formulation. These instruments are essential for ensuring the quality and consistency of biologics, as even small variations in the production process can have a significant impact on the final product. As a result of the growing demand for biologics, these instruments manufacturers are developing new instruments and technologies to improve the efficiency and productivity of bioprocessing. Thus, a key trend that is opening up potential for the industry to grow is the growing demand for biologics. These new developments are mostly to blame for the market's overall growth.

Bioprocess Instruments Market Segmentation

• 

• Request a Free Sample to learn more about this report

• By Types

Based on type, the market is classified into cell expansion, flow cytometry, biologics safety testing, cell line development, tangential flow filtration, cell counters, virus filtration, cell culture, pyrogen testing & single-use bioprocessing.

• By Application

Based on the market is categorized into pharmaceutical industry, biopharmaceutical industry, R&D labs & medical laboratories.

DRIVING FACTORS

"Biopharmaceuticals that Give the Market Extra Boost"

The increasing demand for biopharmaceuticals is one of the key driving factors in the bioprocess instruments industry. Biopharmaceuticals are drugs that are derived from living organisms, such as bacteria, yeast, or mammalian cells, and are used to treat a variety of diseases such as cancer, autoimmune disorders, and genetic diseases. As the demand for biopharmaceuticals continues to rise, there is a corresponding increase in the need for bioprocess to manufacture these drugs. They are used to optimize the production of biopharmaceuticals by monitoring and controlling various process parameters, such as pH, temperature, and oxygen levels. In addition to the increasing demand for biopharmaceuticals, there are also other factors contributing to the growth of the whole market, such as advancements in technology. As a result, the market is expected to continue to grow in the coming years. As a result, the growth, and the increasing demand for biopharmaceuticals will boost the market. It will contribute to the expansion of the healthcare industry and it will improve the overall bioprocess instruments market growth.

"Technological Advancement to Encourage Market Expansion"

Technological advancements are another key driving factor in the industry. Advances in technology have led to the development of more efficient, accurate, and reliable instruments. Single-use technologies have been developed for use in bioprocessing to reduce the risk of contamination and to increase flexibility in manufacturing. These technologies include single-use bioreactors, mixers, and filters. High-throughput screening (HTS) is a method used to quickly and efficiently screen large numbers of compounds for their ability to bind to a specific target. HTS is used in drug discovery and development, and bioprocess instruments have been developed to enable high-throughput screening of biologics. Process analytical technology (PAT) involves the use of sensors and advanced analytics to monitor and control manufacturing processes in real-time. PAT enables manufacturers to optimize their processes, reduce variability, and increase product quality. As a result, these factors are collectively promoting market expansion, increasing company revenues. As a result, above mentioned factors will help the market to boost.

RESTRAINING FACTORS

"High Cost to Impede Market Expansion"

The factor hindering the growth of the market is the high cost of the product. They are often expensive, which can limit their adoption, particularly in developing countries or small-scale operations. These limitations limit the market's overall growth. This may be a significant issue limiting market expansion. If this problem is fixed, the market will start to grow right away.

Bioprocess Instruments Market Regional Insights

• 

• Request a Free Sample to learn more about this report

"North America Dominating the Market Across the Globe"

The market for bioprocess instruments in North America has benefited from the region's expanding industrial development, and various driving factors which has increased the potential sectors as this region is the largest user of the product. The key factor driving the growth of the bioprocess instruments market share is the growing demand of product use in pharmaceutical industry, biopharmaceutical industry, R&D labs & medical laboratories one of the major reasons to drive the market. Rapid urbanization developments will further boost the overall market.

KEY INDUSTRY PLAYERS

"Leading Manufacturers to Boost Product Demand"

Study includes information on the market players and where they stand within the sector. Data is being collected and made available through proper research, mergers, technical advancement, growing production facilities, and cooperation. The study on materials offers details on manufacturers, regions, types, applications, sales channels, distributors, traders, dealers, research findings, and more.

List of Market Players Profiled

• Thermo Fisher Scientific (U.S.)
• BD (U.S.)
• Abbott (U.S.)
• PerkinElmer (U.S.)

REPORT COVERAGE

The study goes into great detail about market segmentation by type and application. The study examines a broad range of participants, including existing and potential market leaders. A considerable market expansion is anticipated as a result of several important factors. In order to provide market insights, the research additionally analyses elements that are probably to boost bioprocess instruments market share. The report makes forecasts for market expansion during the projected time period. The objective of the regional study is to explain why one region dominates the worldwide market. There are a lot of issues that have all been carefully considered that prevent the industry from growing. The research also contains a market strategic analysis. It includes thorough market information.